Investigation of Des-Arginin(9)-Bradykinin, Angiotensin II and mtDNA in patients with COVID-19 as a biomarker for the time-course of the disease
- Conditions
- 07.1
- Registration Number
- DRKS00030005
- Lead Sponsor
- Klinik für Anästhesiologie und operative Intensivmedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
positive SARS-CoV-2 PCR test
- treatment on intensive care unit
Exclusion Criteria
none
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Concentration of Des-Arg(9)-Bradykinin, Angiotensin II und mtDNA 72h after study inclusion.
- Secondary Outcome Measures
Name Time Method Hospital Mortality<br>ROTEM-Analysis<br>Multiplate-Analysis<br>Murray-Score for ARDS<br>SOFA-Score<br>ECMO-Therapy<br>CRP<br>PCT<br>Lymphocytes<br>GOT<br>GPT<br>LDH<br>D-Dimers<br>Fibrinogen